Investigative Medicine Division
We aim to rapidly translate innovative science into patient benefit across a range of disease areas. From molecular biology and target discovery, through to interventional medicine and informing policy, we bring together researchers in a diverse range of specialties including acute stroke, dementia and immunology.
The effects of fasting on ischemic infarcts in the rat
Schneider AM. et al, (2022)
Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8+ T Cells in the Face of Pre-Existing Humoral Immunity.
Zheng MZM. et al, (2022), J Immunol, 209, 1832 - 1836
Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1.
Peng R. et al, (2022), EMBO Rep
Defective iron homeostasis and hematological abnormalities in Niemann-Pick disease type C1
Chen OCW. et al, (2022), Wellcome Open Research, 7, 267 - 267
Reinventing the Penumbra — the Emerging Clockwork of a Multi-modal Mechanistic Paradigm
Walther J. et al, (2022), Translational Stroke Research
6 July 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
29 September 2022
The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.
5 August 2022
Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.